---
document_datetime: 2025-12-29 14:00:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/macugen.html
document_name: macugen.html
version: success
processing_time: 0.1195135
conversion_datetime: 2025-12-30 03:38:58.570963
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Macugen

[RSS](/en/individual-human-medicine.xml/66219)

##### Withdrawn

This medicine's authorisation has been withdrawn

pegaptanib Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Macugen](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 17 December 2018, the European Commission withdrew the marketing authorisation for Macugen (pegaptanib sodium) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, PharmaSwiss Ceska Republika s.r.o, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Macugen was granted marketing authorisation in the EU on 31 January 2006 for the treatment of neovascular (wet) macular degeneration (AMD).

The marketing authorisation was initially valid for a 5- year period. It was renewed for an additional 5-year period in 2010 and granted unlimited validity in 2015. The product had not been marketed in the EU since 1 January 2019.

The European Public Assessment Report (EPAR) for Macugen is updated to indicate that the marketing authorisation is no longer valid.

Macugen : EPAR - Summary for the public

English (EN) (520.99 KB - PDF)

**First published:** 31/05/2007

**Last updated:** 27/06/2019

[View](/en/documents/overview/macugen-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-413)

български (BG) (663.47 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/bg/documents/overview/macugen-epar-summary-public_bg.pdf)

español (ES) (596.59 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/es/documents/overview/macugen-epar-summary-public_es.pdf)

čeština (CS) (637.04 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/cs/documents/overview/macugen-epar-summary-public_cs.pdf)

dansk (DA) (596.95 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/da/documents/overview/macugen-epar-summary-public_da.pdf)

Deutsch (DE) (597.88 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/de/documents/overview/macugen-epar-summary-public_de.pdf)

eesti keel (ET) (596.17 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/et/documents/overview/macugen-epar-summary-public_et.pdf)

ελληνικά (EL) (682.05 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/el/documents/overview/macugen-epar-summary-public_el.pdf)

français (FR) (599.24 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/fr/documents/overview/macugen-epar-summary-public_fr.pdf)

italiano (IT) (649.91 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/it/documents/overview/macugen-epar-summary-public_it.pdf)

latviešu valoda (LV) (648.04 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/lv/documents/overview/macugen-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (602.49 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/lt/documents/overview/macugen-epar-summary-public_lt.pdf)

magyar (HU) (636.13 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/hu/documents/overview/macugen-epar-summary-public_hu.pdf)

Malti (MT) (647.6 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/mt/documents/overview/macugen-epar-summary-public_mt.pdf)

Nederlands (NL) (595.16 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/nl/documents/overview/macugen-epar-summary-public_nl.pdf)

polski (PL) (635.92 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/pl/documents/overview/macugen-epar-summary-public_pl.pdf)

português (PT) (597.31 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/pt/documents/overview/macugen-epar-summary-public_pt.pdf)

română (RO) (602.5 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/ro/documents/overview/macugen-epar-summary-public_ro.pdf)

slovenčina (SK) (590.75 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/sk/documents/overview/macugen-epar-summary-public_sk.pdf)

slovenščina (SL) (620.21 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/sl/documents/overview/macugen-epar-summary-public_sl.pdf)

Suomi (FI) (583.77 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/fi/documents/overview/macugen-epar-summary-public_fi.pdf)

svenska (SV) (595.25 KB - PDF)

**First published:**

31/05/2007

**Last updated:**

27/06/2019

[View](/sv/documents/overview/macugen-epar-summary-public_sv.pdf)

## Product information

Macugen : EPAR - Product Information

English (EN) (832.53 KB - PDF)

**First published:** 03/08/2009

**Last updated:** 27/06/2019

[View](/en/documents/product-information/macugen-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-145)

български (BG) (1.47 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/bg/documents/product-information/macugen-epar-product-information_bg.pdf)

español (ES) (801.14 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/es/documents/product-information/macugen-epar-product-information_es.pdf)

čeština (CS) (1.25 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/cs/documents/product-information/macugen-epar-product-information_cs.pdf)

dansk (DA) (793.88 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/da/documents/product-information/macugen-epar-product-information_da.pdf)

Deutsch (DE) (790.46 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/de/documents/product-information/macugen-epar-product-information_de.pdf)

eesti keel (ET) (767.96 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/et/documents/product-information/macugen-epar-product-information_et.pdf)

ελληνικά (EL) (1.61 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/el/documents/product-information/macugen-epar-product-information_el.pdf)

français (FR) (793.99 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/fr/documents/product-information/macugen-epar-product-information_fr.pdf)

hrvatski (HR) (826.96 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/hr/documents/product-information/macugen-epar-product-information_hr.pdf)

íslenska (IS) (779.73 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/is/documents/product-information/macugen-epar-product-information_is.pdf)

italiano (IT) (772.63 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/it/documents/product-information/macugen-epar-product-information_it.pdf)

latviešu valoda (LV) (1.4 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/lv/documents/product-information/macugen-epar-product-information_lv.pdf)

lietuvių kalba (LT) (976.35 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/lt/documents/product-information/macugen-epar-product-information_lt.pdf)

magyar (HU) (1.23 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/hu/documents/product-information/macugen-epar-product-information_hu.pdf)

Malti (MT) (1.42 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/mt/documents/product-information/macugen-epar-product-information_mt.pdf)

Nederlands (NL) (872.52 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/nl/documents/product-information/macugen-epar-product-information_nl.pdf)

norsk (NO) (793.02 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/no/documents/product-information/macugen-epar-product-information_no.pdf)

polski (PL) (1.35 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/pl/documents/product-information/macugen-epar-product-information_pl.pdf)

português (PT) (765.25 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/pt/documents/product-information/macugen-epar-product-information_pt.pdf)

română (RO) (1000.2 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/ro/documents/product-information/macugen-epar-product-information_ro.pdf)

slovenčina (SK) (1.24 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/sk/documents/product-information/macugen-epar-product-information_sk.pdf)

slovenščina (SL) (1.39 MB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/sl/documents/product-information/macugen-epar-product-information_sl.pdf)

Suomi (FI) (821.74 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/fi/documents/product-information/macugen-epar-product-information_fi.pdf)

svenska (SV) (774.71 KB - PDF)

**First published:**

03/08/2009

**Last updated:**

27/06/2019

[View](/sv/documents/product-information/macugen-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0065 20/07/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Macugen : EPAR - All Authorised presentations

English (EN) (457.96 KB - PDF)

**First published:** 05/02/2008

**Last updated:** 27/06/2019

[View](/en/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-918)

български (BG) (538.8 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/bg/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_bg.pdf)

español (ES) (458.33 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/es/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_es.pdf)

čeština (CS) (540.02 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/cs/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (460.05 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/da/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (458.67 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/de/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (460.41 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/et/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (519.4 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/el/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_el.pdf)

français (FR) (458.25 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/fr/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (458.12 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/it/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (539.76 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/lv/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (533.6 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/lt/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (536.46 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/hu/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (537.49 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/mt/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (457.9 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/nl/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_nl.pdf)

polski (PL) (541.48 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/pl/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_pl.pdf)

português (PT) (458.34 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/pt/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_pt.pdf)

română (RO) (523 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/ro/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (535.63 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/sk/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (461.58 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/sl/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (459.56 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/fi/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (458.3 KB - PDF)

**First published:**

05/02/2008

**Last updated:**

27/06/2019

[View](/sv/documents/all-authorised-presentations/macugen-epar-all-authorised-presentations_sv.pdf)

Macugen : EPAR - Conditions imposed on member states for safe and effective use - Annex IV

English (EN) (477.37 KB - PDF)

**First published:** 13/07/2007

**Last updated:** 27/06/2019

[View](/en/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_en.pdf)

[Other languages (21)](#file-language-dropdown-137)

български (BG) (579.31 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/bg/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_bg.pdf)

español (ES) (477.76 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/es/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_es.pdf)

čeština (CS) (568.25 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/cs/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_cs.pdf)

dansk (DA) (476.73 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/da/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_da.pdf)

Deutsch (DE) (478.44 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/de/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_de.pdf)

eesti keel (ET) (473.23 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/et/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_et.pdf)

ελληνικά (EL) (571.1 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/el/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_el.pdf)

français (FR) (484.43 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/fr/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fr.pdf)

italiano (IT) (476.75 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/it/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_it.pdf)

latviešu valoda (LV) (576.29 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/lv/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lv.pdf)

lietuvių kalba (LT) (543.73 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/lt/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lt.pdf)

magyar (HU) (533.53 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/hu/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_hu.pdf)

Malti (MT) (1.03 MB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/mt/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_mt.pdf)

Nederlands (NL) (477.91 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/nl/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_nl.pdf)

polski (PL) (573.21 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/pl/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pl.pdf)

português (PT) (477.16 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/pt/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pt.pdf)

română (RO) (546.55 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/ro/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_ro.pdf)

slovenčina (SK) (569.93 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/sk/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sk.pdf)

slovenščina (SL) (561.68 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/sl/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sl.pdf)

Suomi (FI) (476.99 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/fi/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fi.pdf)

svenska (SV) (477.99 KB - PDF)

**First published:**

13/07/2007

**Last updated:**

27/06/2019

[View](/sv/documents/conditions-member-states/macugen-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sv.pdf)

## Product details

Name of medicine Macugen Active substance pegaptanib International non-proprietary name (INN) or common name pegaptanib Therapeutic area (MeSH) Wet Macular Degeneration Anatomical therapeutic chemical (ATC) code S01LA03

### Pharmacotherapeutic group

Ophthalmologicals

### Therapeutic indication

Macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD).

## Authorisation details

EMA product number EMEA/H/C/000620 Marketing authorisation holder

PharmaSwiss Ceska Republika s.r.o

Jankovcova 1569/2c

Marketing authorisation issued 31/01/2006 Revision 15

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Macugen : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (688.92 KB - PDF)

**First published:** 03/08/2009

**Last updated:** 27/06/2019

[View](/en/documents/procedural-steps-after/macugen-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Macugen : EPAR - Procedural steps taken before authorisation

English (EN) (482.92 KB - PDF)

**First published:** 31/05/2007

**Last updated:** 27/06/2019

[View](/en/documents/procedural-steps/macugen-epar-procedural-steps-taken-authorisation_en.pdf)

Macugen : EPAR - Scientific Discussion

English (EN) (984.11 KB - PDF)

**First published:** 31/05/2007

**Last updated:** 27/06/2019

[View](/en/documents/scientific-discussion/macugen-epar-scientific-discussion_en.pdf)

#### More information on Macugen

- [EMEA-000611-PIP01-09 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000611-pip01-09)
- [Macugen - withdrawal of application for variation to marketing authorisation](/en/medicines/human/variation/macugen)

**This page was last updated on** 02/12/2022

## Share this page

[Back to top](#main-content)